Drug Discovery World

OCTOBER 31, 2023

Professor Andy Whiting and Dr Tony Lockett discuss how specific levels of a protein could be used to advance drug development in neurodegenerative diseases. The neurodegenerative landscape The World Health Organization has estimated that neurological disorders affect up to 1 billion people across the world 2.

Drug Development 147

Drug Development Disease Drugs Clinical Trials 147

Drug Target Review

JULY 4, 2023

The drivers behind the demand for ADCs Providing more targeted therapeutic options in the oncology space has underpinned the rapid growth of the ADC market; between 2016 to 2020, the US ADC market grew by 45 percent to a value of nearly $1.5 Petra holds a D.Phil in synthetic organic chemistry and am MBA from Imperial College London.

Small Molecule 145

Small Molecule Drugs Clinical Pharmacology Trials 145

Drug Hunter

AUGUST 21, 2023

Obtaining adequate drug exposure in the brain is key to treating CNS diseases effectively. The BBB is composed of specialized brain endothelial cells that regulate the distribution of molecules into and out of the brain from the blood. Recently, Dennis Koester gave us a crash course in CNS drug discovery in a Drug Hunter Flash Talk.

Drugs 206

Drugs Disease Targeted Protein Degradation Screening Hits 206